Trump Says Becton Dickinson to Invest $3 Billion in US Manufacturing as 'Strong' Medical Device Tariffs Loom by Year-End

10/6/2026
Impact: 80
Healthcare

Becton Dickinson and Co (NYSE: BDX) plans to invest $3 billion in U.S. medical-product manufacturing, with over $1 billion earmarked for expansion in Nebraska. This investment is linked to anticipated strong medical device tariffs by year-end, aimed at increasing domestic production of syringes, needles, and lab kits. In its latest earnings report, BD reported third-quarter revenue of $5.0 billion, a 5.4% increase year-over-year, and adjusted EPS of $3.23, with expectations for continued revenue growth.

AI summary, not financial advice

Share: